febuxostat has been researched along with Colorectal Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hayakawa, Y; Higashishima, N; Hikiba, Y; Hirata, Y; Ichinose, M; Ihara, S; Iwamoto, Y; Kinoshita, H; Koike, K; Kushiyama, A; Nakata, R; Niikura, R; Okamoto, M; Sano, M; Suzuki, N; Woods, SL; Worthley, D; Yamada, A | 1 |
1 other study(ies) available for febuxostat and Colorectal Neoplasms
Article | Year |
---|---|
Alpha-Blockers As Colorectal Cancer Chemopreventive: Findings from a Case-Control Study, Human Cell Cultures, and
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Apoptosis; Aspirin; Case-Control Studies; Cell Proliferation; Colorectal Neoplasms; Doxazosin; Febuxostat; Female; Gout Suppressants; Humans; Male; Mice; Mice, Inbred C57BL; Middle Aged; Prognosis; Retrospective Studies; Tumor Cells, Cultured | 2019 |